首页> 美国卫生研究院文献>American Journal of Translational Research >Medial tibial subchondral bone is the key target for extracorporeal shockwave therapy in early osteoarthritis of the knee
【2h】

Medial tibial subchondral bone is the key target for extracorporeal shockwave therapy in early osteoarthritis of the knee

机译:胫骨软骨下内侧骨是膝关节早期骨关节炎的体外冲击波治疗的主要目标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Extracorporeal shockwave therapy (ESWT) is a new non-invasive method to induce tissue regeneration and repair the damaged osteoarthritis (OA) of knee. Previous studies suggested subchondral bone as the key target for OA treatment. However, the relationship of the effect and different locations of subchondral bone is unknown. The purpose of the study was to investigate whether the subchondral bone of medial tibia as the target for ESWT in early OA knee treatment and compared with various locations on lateral tibia and femur condyles. Application of ESWT on the medial tibial subchondral bone ameliorated 38% in gross pathological OA changes (compared to OA, P < 0.001), 94 % in OARSI score (compared to OA, P < 0.001) and 45% in cartilage defect (compared to OA, P < 0.001), 17% in bone mineral density (compared to OA, P < 0.001) than lateral tibia and femur. In micro-CT analysis, ESWT on medial tibial subchondral bone increased bone volume (61% vs 44% in tibia and 62% vs 53% in femur, P < 0.05), yield stress (6 MPa vs 4 MPa in tibia and 4 MPa vs 2 MPa in femur, P < 0.05) and decreased bone porosity (38% vs 53% in tibia and 37% vs 46% in femur, P < 0.05) than OA. The TUNEL, PCNA and osteocalcin significantly influenced the levels of molecular expression in different locations of ESWT application. Our results confirm that application of ESWT to the medial tibial subchondral bone has more effective therapy for OA knee than lateral locations of joint knee.
机译:体外冲击波疗法(ESWT)是一种新的非侵入性方法,可以诱导组织再生和修复受损的膝盖骨关节炎(OA)。先前的研究建议软骨下骨作为OA治疗的主要目标。但是,效果与软骨下骨不同位置之间的关系尚不清楚。该研究的目的是调查在早期OA膝关节治疗中,胫骨内侧软骨下骨是否作为ESWT的靶标,并与胫骨外侧和股骨con的各个位置进行比较。 ESWT在胫骨软骨下内侧骨上的应用可减轻38%的病理性OA变化(与OA,P <0.001),94%的OARSI评分(与OA,P <0.001)和45%的软骨缺损(与OA,P <0.001),比侧胫骨和股骨的骨矿物质密度(OA,P <0.001)高17%。在micro-CT分析中,胫骨软骨下骨上的ESWT增加了骨体积(胫骨分别为61%vs 44%,股骨为62%vs 53%,P <0.05),屈服应力(胫骨中6 MPa vs 4 MPa和4 MPa)与OA相比,股骨相对于2 MPa,P <0.05),骨孔隙率降低(胫骨38%对53%,股骨37%对46%,P <0.05)。 TUNEL,PCNA和骨钙素显着影响了ESWT应用中不同位置的分子表达水平。我们的结果证实,将ESWT应用于胫骨软骨下内侧骨对OA膝关节的治疗比对膝关节外侧位置的治疗更为有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号